These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 26325616)

  • 1. Utility of imaging techniques in the diagnosis of oral cancer.
    Sarrión Pérez MG; Bagán JV; Jiménez Y; Margaix M; Marzal C
    J Craniomaxillofac Surg; 2015 Nov; 43(9):1880-94. PubMed ID: 26325616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
    Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT
    J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of CT, MRI, and F-18 FDG PET/CT for initial N-staging of oral squamous cell carcinoma: a cost-effectiveness analysis.
    Burian E; Palla B; Callahan N; Pyka T; Wolff C; von Schacky CE; Schmid A; Froelich MF; Rübenthaler J; Makowski MR; Gassert FG
    Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3870-3877. PubMed ID: 35606526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of cone-beam computed tomography (CBCT) in comparison to conventional computed tomography (CT) and magnetic resonance imaging (MRI) for the detection of bone invasion in oral squamous cell cancer (OSCC): a prospective study.
    Straub A; Linz C; Lapa C; Hartmann S; Kübler AC; Müller-Richter UDA; Faber J; Bley T; Brumberg J; Kertels O; Brands RC
    BMC Oral Health; 2024 Mar; 24(1):341. PubMed ID: 38493083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of fused FDG PET/MRI, PET/CT, MRI, and CT imaging for assessing surrounding tissue invasion of advanced buccal squamous cell carcinoma.
    Huang SH; Chien CY; Lin WC; Fang FM; Wang PW; Lui CC; Huang YC; Hung BT; Tu MC; Chang CC
    Clin Nucl Med; 2011 Jul; 36(7):518-25. PubMed ID: 21637051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography-computed tomography versus positron emission tomography-magnetic resonance imaging for diagnosis of oral squamous cell carcinoma: A pilot study.
    Schlittenbauer T; Zeilinger M; Nkenke E; Kreißel S; Wurm MC; Lell M; Kuwert T; Beck M
    J Craniomaxillofac Surg; 2015 Dec; 43(10):2129-35. PubMed ID: 26498514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography/computerized tomography (PET/CT) scanning for preoperative staging of patients with oral/head and neck cancer.
    Nahmias C; Carlson ER; Duncan LD; Blodgett TM; Kennedy J; Long MJ; Carr C; Hubner KF; Townsend DW
    J Oral Maxillofac Surg; 2007 Dec; 65(12):2524-35. PubMed ID: 18022480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical values of (18) F-FDG PET/CT in oral cavity cancer with dental artifacts on CT or MRI.
    Hong HR; Jin S; Koo HJ; Roh JL; Kim JS; Cho KJ; Choi SH; Nam SY; Kim SY
    J Surg Oncol; 2014 Nov; 110(6):696-701. PubMed ID: 24995957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography using [18F]fluorodeoxyglucose (FDG-PET) in the clinically negative neck: is it likely to be superior?
    Brouwer J; de Bree R; Comans EF; Castelijns JA; Hoekstra OS; Leemans CR
    Eur Arch Otorhinolaryngol; 2004 Oct; 261(9):479-83. PubMed ID: 14685887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative value of ultrasound, computed tomography and positron emission tomography imaging in the clinically node-negative neck in oral cancer.
    Chaukar D; Dandekar M; Kane S; Arya S; Purandare N; Rangarajan V; Deshmukh A; Pai P; Chaturvedi P; D'Cruz A
    Asia Pac J Clin Oncol; 2016 Jun; 12(2):e332-8. PubMed ID: 25131685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the accuracy of target volume delineation by combined use of computed tomography, magnetic resonance imaging and positron emission tomography in head and neck carcinomas.
    Chauhan D; Rawat S; Sharma MK; Ahlawat P; Pal M; Gupta G; Dewan A; Gupta M; Sharma S; Dodagoudar C; Pahuja A; Mitra S; Sharma SK
    J Cancer Res Ther; 2015; 11(4):746-51. PubMed ID: 26881512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging and computed tomography in the assessment of mandibular invasion by squamous cell carcinoma of the oral cavity. Influence on surgical management and post-operative course.
    Farrow ES; Boulanger T; Wojcik T; Lemaire AS; Raoul G; Julieron M
    Rev Stomatol Chir Maxillofac Chir Orale; 2016 Nov; 117(5):311-321. PubMed ID: 27373806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staging of untreated squamous cell carcinoma of buccal mucosa with 18F-FDG PET: comparison with head and neck CT/MRI and histopathology.
    Yen TC; Chang JT; Ng SH; Chang YC; Chan SC; Wang HM; See LC; Chen TM; Kang CJ; Wu YF; Lin KJ; Liao CT
    J Nucl Med; 2005 May; 46(5):775-81. PubMed ID: 15872350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of FDG PET in patients with squamous cell carcinomas of the oral cavity.
    Kim SY; Roh JL; Kim JS; Ryu CH; Lee JH; Cho KJ; Choi SH; Nam SY
    Eur J Surg Oncol; 2008 Feb; 34(2):208-15. PubMed ID: 17482789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of 18F-FDG-PET/CT for staging of oral squamous cell carcinoma.
    Pentenero M; Cistaro A; Brusa M; Ferraris MM; Pezzuto C; Carnino R; Colombini E; Valentini MC; Giovanella L; Spriano G; Gandolfo S
    Head Neck; 2008 Nov; 30(11):1488-96. PubMed ID: 18767178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
    Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
    Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local resectability assessment of head and neck cancer: Positron emission tomography/MRI versus positron emission tomography/CT.
    Sekine T; Barbosa FG; Delso G; Burger IA; Stolzmann P; Ter Voert EE; Huber GF; Kollias SS; von Schulthess GK; Veit-Haibach P; Huellner MW
    Head Neck; 2017 Aug; 39(8):1550-1558. PubMed ID: 28500749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loco-regional recurrence after surgical treatment of oral squamous cell carcinoma: Proposals for follow-up imaging based on literature, national guidelines and institutional experience.
    Loeffelbein DJ; Eiber M; Mayr P; Souvatzoglou M; Mücke T; von Bomhard A; Kesting MR; Wolff KD
    J Craniomaxillofac Surg; 2015 Oct; 43(8):1546-52. PubMed ID: 26189143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodal imaging analysis of an orthotopic head and neck cancer mouse model and application of anti-CD137 tumor immune therapy.
    Vahle AK; Hermann S; Schäfers M; Wildner M; Kerem A; Öztürk E; Jure-Kunkel M; Franklin C; Lang S; Brandau S
    Head Neck; 2016 Apr; 38(4):542-9. PubMed ID: 25482887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.